Replies to post #173252 on NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

“Just one example. THEY [U]KNOW[/U] THE MEDIAN. Those of us on the outside, bears and longs, have it nailed down to ummm.....between 20 and 30 months -- LOL.

Let's pretend they know what it is, and they know its above 26. That's an advantage.“

Here, Here! Harrumph!

That is exactly right. They may also know a thing or two about product inventory and when it was initiated and drained. They know way too much at this point to continue this dilution and more.

[sukus]

I got it Flipper.

[ilovetech]

Flipper44,

You laid that out like (Peter Falk) in Colombo. Very tantalizing to say the least!

Best,
ILT

[JTORENCE]

flipper thank you for that response. But wouldn't it be an SEC violation to withhold material info that may have an impact on the share price?

Have a good evening.

[joeycav11]

So that would make Linda not as reputable as she would like everyone to believe.If She is holding back results to gain more cheap shares.
And patients die while waiting for results. If this is happening it would be sad.
We better get some decent updates by the June cancer conference.
Shes gambling with her reputation and any investigation into hedge fund manipulation could be comprimised

[pgsd]

I cannot disagree with you unfortunately. IMO you might consider forwarding this to the company, not that they will comment but still good to challenge them on this.

[Lykiri]

Flipper44,

You wrote:

“It just seems the new obligations for reserving rooms with Advent (hello that's Toucan) at the empty arms hotel is just a reason to transfer shares from those with less knowledge, to those with more knowledge”

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140916791

Maybe not so empty rooms!

Pilar Velasco Sevillano

GMP Production Scientist
Advent Bioservices
I.E.S. Benjamín Rua, Madrid
London, Greater London, Verenigd Koninkrijk
270 270 connecties

Hi!

I´ve participated in Spain in several clinical trials like a manager manufacturing to producing mesenchymal stem cells and mononuclear cells under GMP conditions, for implantation in hematology patients and like regenerative treatment in patients with acute myocardial infarction. I worked mainly with cell cultures at unit cell therapy, quality control, microbiological control and staining techniques.

Currently, I have started a fabulous project where I am going to be involved in performing dendritic cell culture as a treatment in oncology patients.


GMP production scientist
Advent Bioservices
sep. 2017 – may 2018: 9 months
London, Reino Unido

Performing dendritic cell culture as a treatment in oncology patients.

https://www.linkedin.com/in/pilar-velasco-sevillano-22026a55/

Best wishes!

[antihama]

Thanks for putting into words what many of us are thinking. You can somewhat justify LP and Company's earlier increase in share count as good for all but this blinded data publication seems to be becoming an excuse for a share grab. We'll see how it all transpires. If it comes out before much dilution, all is forgiven, if it comes out afterwards, well, there will be many irate investors.

[Virgilio]

Anyone should read this post, I believe, Flipper.

[Umibe5690]

I think you are wrong. IMHO, the blended mOS is below 25 months.